THE US Food and Drug
Administration (FDA) Office of
Prescription Drug Promotion has
hit Pfizer subsidiary Hospira with an
untitled letter over the company’s
“misleading” YouTube video on its
sedative Precedex, according to
the Regulatory Affairs Professionals
Society (RAPS).
FDA is taking issue with the way
the video “makes representations
about the use of Precedex for
intensive care unit sedation.”
Hospira has been ordered to
immediately cease violating the
FD&C Act and confirm compliance
in writing.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jan 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jan 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.